The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey

Clinical Rheumatology

Volumn 35, Issue 8, 2016, Pages 2063-2071

  Pamuk, Ömer Nuri ^a   Dönmez, Salim ^a   Calayır, Gökçe Büşra ^b   Pamuk, Gülsüm Emel ^b  

^a TRAKYA UNIVERSITY   (Turkey)

^b TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV); Eosinophilic granulomatosis with polyangiitis (Churg Strauss) (EGPA); Epidemiology; Granulatomatosis with polyangiitis (Wegener) (GPA); Microscopic polyangiitis (MPA)

Indexed keywords

CREATININE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; EOSINOPHILIC POLYANGIITIS; EPIDEMIOLOGICAL DATA; FEMALE; GRANULOMATOSIS; GRANULOMATOUS POLYANGIITIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME TO TREATMENT; TURKEY (REPUBLIC); AGE DISTRIBUTION; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; BLOOD; CLASSIFICATION; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; SEX RATIO; TURKEY; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE; TURKEY; YOUNG ADULT;

EID: 84961233706     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-016-3232-y     Document Type: Article

References (41)

1. Gibelin A, Maldini C, Mahr A (2011) Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement. Semin Respir Crit Care Med 32:264–273
2. Piram M, Maldini C, Mahr A (2012) Effect of race/ethnicity on risk, presentation and course of connective tissue diseases and primary systemic vasculitides. Curr Opin Rheumatol 24:193–200
3. Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG et al (2011) Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford) 50:1916–1920
4. Cao Y, Schmitz JL, Yang J, Hogan SL, Bunch D, Hu Y et al (2011) DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol 22:1161–1167
5. Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K et al (2006) Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol 1:1016–1022
6. Haugeberg G, Bie R, Bendvold A, Larsen AS, Johnsen V (1998) Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol 17:364–368
7. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–99
8. Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, Rodriguez-Ledo P, Llorca J (2003) The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 49(3):388–393
9. Gatenby PA, Lucas RM, Engelsen O, Ponsonby AL, Clements M (2009) Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation? Arthritis Rheum 61:1417–1424
10. Mahr A, Guillevin L, Poissonnet M, Aymé S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51:92–99
11. Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337
12. Gibson A, Stamp LK, Chapman PT, O’Donnell JL (2006) The epidemiology of Wegener’s granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology (Oxford) 45:624–628
13. Mahr AD, Neogi T, Merkel PA (2006) Epidemiology of Wegener’s granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol 24(2 Suppl 41):S82–S91
14. Scott DG, Bacon PA, Elliott PJ, Tribe CR, Wallington TB (1982) Systemic vasculitis in a district general hospital 1972–1980: clinical and laboratory features, classification and prognosis of 80 cases. Q J Med 51:292–311
15. Andrews M, Edmunds M, Campbell A, Walls J, Feehally J (1990) Systemic vasculitis in the 1980s—is there an increasing incidence of Wegener’s granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond 24:284–288
16. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227
17. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192
18. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107
19. Fries JF, Hunder GG, Bloch DA, Michel BA, Arend WP, Calabrese LH et al (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33:1135–1136
20. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100
21. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87:671–678
22. Merkel PA (2012) Defining disease activity and damage in patients with small-vessel vasculitis. Cleve Clin J Med 79(Suppl 3):S11–S15
23. Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 48:1560–1565
24. Herlyn K, Buckert F, Gross WL, Reinhold-Keller E (2014) Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology (Oxford) 53:882–889
25. Watts RA, Al-Taiar A, Scott DG, Macgregor AJ (2009) Prevalence and incidence of Wegener’s granulomatosis in the UK general practice research database. Arthritis Rheum 61:1412–1416
26. Faurschou M, Helleberg M, Obel N, Baslund B (2013) Incidence of granulomatosis with polyangiitis (Wegener’s) in Greenland and the Faroe Islands: epidemiology of an ANCA-associated vasculitic syndrome in two ethnically distinct populations in the North Atlantic area. Clin Exp Rheumatol 31(1 Suppl 75):S52–S55
27. Koldingsnes W, Nossent H (2000) Epidemiology of Wegener’s granulomatosis in northern Norway. Arthritis Rheum 43:2481–2487
28. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA (1996) The epidemiology of Wegener’s granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 39:87–92
29. Ormerod AS, Cook MC (2008) Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales. Intern Med J 38:816–823
30. Panagiotakis SH, Perysinakis GS, Kritikos H, Vassilopoulos D, Vrentzos G, Linardakis M et al (2009) The epidemiology of primary systemic vasculitides involving small vessels in Crete (southern Greece): a comparison of older versus younger adult patients. Clin Exp Rheumatol 27:409–415
31. Takala JH, Kautiainen H, Malmberg H, Leirisalo-Repo M (2008) Incidence of Wegener’s granulomatosis in Finland 1981–2000. Clin Exp Rheumatol 26(3 Suppl 49):S81–S85
32. Dadoniene J, Kirdaite G, Mackiewicz Z, Rimkevicius A, Haugeberg G (2005) Incidence of primary systemic vasculitis in Vilnius: a university hospital population based study. Ann Rheum Dis 64(2):335–336
33. Hissaria P, Cai FZ, Ahern M, Smith M, Gillis D, Roberts-Thomson P (2008) Wegener’s granulomatosis: epidemiological and clinical features in a South Australian study. Intern Med J 38:776–780
34. Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter HH, Raspe HH, Gross WL (2000) Giant cell arteritis is more prevalent in urban than rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology (Oxford) 39(12):1396–1402
35. Cakır N, Pamuk Ö, Derviş E, Imeryüz N, Uslu H, Benian Ö et al (2012) The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 32:895–908
36. Watts RA, Lane SE, Bentham G, Scott DG (2000) Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 43:414–419
37. Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG (2001) Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis 60:170–172
38. Watts RA, Scott DG (1997) Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol 11:191–217
39. Watts RA, Scott DG, Jayne DR, Ito-Ihara T, Muso E, Fujimoto S et al (2008) Renal vasculitis in Japan and the UK—are there differences in epidemiology and clinical phenotype? Nephrol Dial Transplant 23:3928–3931
40. Chen M, Yu F, Zhang Y, Zhao MH (2005) Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre. Postgrad Med J 81:723–727
41. Li ZY, Chang DY, Zhao MH, Chen M (2014) Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated vasculitis: a study of 439 cases in a single Chinese center. Arthritis Rheumatol 66:1920–1926